UFP Technologies Inc.
UFPT
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.83B
Close$
$355.72
49.9% upside
Current Fair Value
49.9% upsideUndervalued by 49.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.83 Billion |
|---|---|
| Enterprise Value | $1.95 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $8.87 |
| Beta | 1.07 |
| Outstanding Shares | 7,721,000 |
Return
| Return on Equity | 15.64% |
|---|---|
| Return on Assets | 10.17% |
| Return on Invested Capital | 15.52% |
Valuation & Multiples
| P/E Ratio | 26.62 |
|---|---|
| PEG | 1470.81 |
| Price to Sales | 3.04 |
| Price to Book Ratio | 4.24 |
| Enterprise Value to Revenue | 3.2 |
| Enterprise Value to EBIT | 21.03 |
| Enterprise Value to Net Income | 28 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.31 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 5, 2026
EPS Estimate
$2.18
Average shareholder expectationRevenue Estimate
$154.78 M
Average shareholder expectationNext Earnings Call
Expected Date
August 3, 2026
EPS Estimate
$2.51
Average shareholder expectationRevenue Estimate
$159.38 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 491.67% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 19.59%▼ 94.29% |
|---|---|
| Total Invested | $401.06M▼ 76.39% |
| Investors Holding | 12▼ 262.00% |
ESG Score
No data
About UFP Technologies Inc.
CEO: R. Jeffrey Bailly Relevant Senate Committees
Finance
Controls corporate tax policy, R&D tax credits, and Medicare reimbursement rates, all of which are critical to the profitability and demand within the company's medical manufacturing business.
Health, Education, Labor, and Pensions
Regulates the FDA, which oversees the medical devices and single-use surgical components that constitute the majority of UFP Technologies' revenue and growth strategy.